What is the difference between Inflectra and Remicade?
Medically reviewed by Drugs.com Last updated on Sep 16, 2019.
Official Answerby Drugs.com
Inflectra (infliximab-dyyb) and Remicade (infliximab) belong to the class of drugs called tumor necrosis factor (TNF) alfa inhibitors.
A biosimilar must have no clinically meaningful safety or effectiveness differences from the reference product, but it is not considered identical like a generic product.
Inflectra can be prescribed for the same uses as Remicade, including rheumatoid arthritis, Crohn’s disease, ankylosing spondylitis, ulcerative colitis, psoriatic arthritis, and plaque psoriasis.
For additional information, see Comparing Inflectra vs Remicade
Related Medical Questions
- What is the difference between Renflexis and Remicade?
- What is the difference between Ixifi and Remicade?
- How many biosimilars have been approved in the United States?
- What are the new drugs for the treatment of plaque psoriasis?
- What are the new drugs for the treatment of rheumatoid arthritis (RA)?